食品微生物特論 期中報告
姓名：李至正
學號：00334012
題目：Bacteriophage therapy for food
Reference List
1. Kwiatek, M., S. Parasion, L. Mizak, R. Gryko, M. Bartoszcze, and J.
Kocik. 2011. Characterization of a bacteriophage, isolated from a cow
with mastitis, that is lytic against Staphylococcus aureus strains. Arch.
Virol.
2. Lim, T. H., D. H. Lee, Y. N. Lee, J. K. Park, H. N. Youn, M. S. Kim, H. J.
Lee, S. Y. Yang, Y. W. Cho, J. B. Lee, S. Y. Park, I. S. Choi, and C. S.
Song. 2011. Efficacy of bacteriophage therapy on horizontal transmission
of Salmonella gallinarum on commercial layer chickens. Avian Dis.
55:435-438.
3. Filippov, A. A., K. V. Sergueev, Y. He, X. Z. Huang, B. T. Gnade, A. J.
Mueller, C. M. Fernandez-Prada, and M. P. Nikolich. 2011.
Bacteriophage-Resistant Mutants in Yersinia pestis: Identification of
Phage Receptors and Attenuation for Mice. PLoS. One. 6:e25486.
4. Burrowes, B., D. R. Harper, J. Anderson, M. McConville, and M. C.
Enright. 2011. Bacteriophage therapy: potential uses in the control of
antibiotic-resistant pathogens. Expert. Rev. Anti. Infect. Ther. 9:775-785.
5. Ryan, E. M., S. P. Gorman, R. F. Donnelly, and B. F. Gilmore. 2011.
Recent advances in bacteriophage therapy: how delivery routes,
formulation, concentration and timing influence the success of phage
therapy. J. Pharm. Pharmacol. 63:1253-1264.
6. Lu, T. K. and M. S. Koeris. 2011. The next generation of bacteriophage
therapy. Curr. Opin. Microbiol. 14:524-531.
7. Alfadhel, M., U. Puapermpoonsiri, S. J. Ford, F. J. McInnes, and C. F.
van der Walle. 2011. Lyophilized inserts for nasal administration
harboring bacteriophage selective for Staphylococcus aureus: in vitro
evaluation. Int. J. Pharm. 416:280-287.
8. Khawaldeh, A., S. Morales, B. Dillon, Z. Alavidze, A. N. Ginn, L.
Thomas, S. J. Chapman, A. Dublanchet, A. Smithyman, and J. R.
Iredell. 2011. Bacteriophage therapy for refractory Pseudomonas
aeruginosa urinary tract infection. J. Med. Microbiol. 60:1697-1700.
9. Doyle, M. P. and M. C. Erickson. 2011. Opportunities for mitigating
pathogen contamination during on-farm food production. Int. J. Food
Microbiol.
10. Connerton, P. L., A. R. Timms, and I. F. Connerton. 2011.
Campylobacter bacteriophages and bacteriophage therapy. J. Appl.
Microbiol. 111:255-265.
11. Vinodkumar, C. S., H. Srinivasa, K. G. Basavarajappa, S.
Geethalakshmi, and N. Bandekar. 2011. Isolation of bacteriophages to
multi-drug resistant Enterococci obtained from diabetic foot: a novel
antimicrobial agent waiting in the shelf? Indian J. Pathol. Microbiol.
54:90-95.
12. Morello, E., E. Saussereau, D. Maura, M. Huerre, L. Touqui, and L.
Debarbieux. 2011. Pulmonary bacteriophage therapy on Pseudomonas
aeruginosa cystic fibrosis strains: first steps towards treatment and
prevention. PLoS. One. 6:e16963.
13. Cooper, C. J., S. P. Denyer, and J. Y. Maillard. 2011. Rapid and
quantitative automated measurement of bacteriophage activity against
cystic fibrosis isolates of Pseudomonas aeruginosa. J. Appl. Microbiol.
110:631-640.
14. Sunagar, R., S. A. Patil, and R. K. Chandrakanth. 2010. Bacteriophage
therapy for Staphylococcus aureus bacteremia in streptozotocin-induced
diabetic mice. Res. Microbiol. 161:854-860.
15. Ramasamy, S., C. Q. Liu, H. Tran, A. Gubala, P. Gauci, J. McAllister,
and T. Vo. 2010. Principles of antidote pharmacology: an update on
prophylaxis, post-exposure treatment recommendations and research
initiatives for biological agents. Br. J. Pharmacol. 161:721-748.
16. Kumari, S., K. Harjai, and S. Chhibber. 2010. Evidence to support the
therapeutic potential of bacteriophage Kpn5 in burn wound infection
caused by Klebsiella pneumoniae in BALB/c mice. J. Microbiol. Biotechnol.
20:935-941.
17. Miller, R. W., E. J. Skinner, A. Sulakvelidze, G. F. Mathis, and C. L.
Hofacre. 2010. Bacteriophage therapy for control of necrotic enteritis of
broiler chickens experimentally infected with Clostridium perfringens.
Avian Dis. 54:33-40.
18. Lin, N. T., P. Y. Chiou, K. C. Chang, L. K. Chen, and M. J. Lai. 2010.
Isolation and characterization of phi AB2: a novel bacteriophage of
Acinetobacter baumannii. Res. Microbiol. 161:308-314.
2
19. Huff, W. E., G. R. Huff, N. C. Rath, and A. M. Donoghue. 2010. Immune
interference of bacteriophage efficacy when treating colibacillosis in
poultry. Poult. Sci. 89:895-900.
20. Santos, T. M., R. O. Gilbert, L. S. Caixeta, V. S. Machado, L. M.
Teixeira, and R. C. Bicalho. 2010. Susceptibility of Escherichia coli
isolated from uteri of postpartum dairy cows to antibiotic and
environmental bacteriophages. Part II: In vitro antimicrobial activity
evaluation of a bacteriophage cocktail and several antibiotics. J. Dairy Sci.
93:105-114.
21. Carmody, L. A., J. J. Gill, E. J. Summer, U. S. Sajjan, C. F. Gonzalez,
R. F. Young, and J. J. LiPuma. 2010. Efficacy of bacteriophage therapy
in a model of Burkholderia cenocepacia pulmonary infection. J. Infect. Dis.
201:264-271.
22. Kallings, L. O. 2009. [Bacteriophage therapy revisited]. Lakartidningen
106:2708.
23. Capparelli, R., N. Nocerino, M. Iannaccone, D. Ercolini, M. Parlato, M.
Chiara, and D. Iannelli. 2010. Bacteriophage therapy of Salmonella
enterica: a fresh appraisal of bacteriophage therapy. J. Infect. Dis.
201:52-61.
24. Klein, G. O. 2009. [Bacteriophage therapy can be the rescue when
antibiotics no longer work]. Lakartidningen 106:2530-2533.
25. Rhoads, D. D., R. D. Wolcott, M. A. Kuskowski, B. M. Wolcott, L. S.
Ward, and A. Sulakvelidze. 2009. Bacteriophage therapy of venous leg
ulcers in humans: results of a phase I safety trial. J. Wound. Care
18:237-3.
26. Gorski, A., R. Miedzybrodzki, J. Borysowski, B. Weber-Dabrowska, M.
Lobocka, W. Fortuna, S. Letkiewicz, M. Zimecki, and G. Filby. 2009.
Bacteriophage therapy for the treatment of infections. Curr. Opin. Investig.
Drugs 10:766-774.
27. Szczaurska-Nowak, K., K. Dabrowska, M. Celka, A. Kurzepa, D.
Nevozhay, J. Wietrzyk, K. Switala-Jelen, D. Syper, G. Pozniak, A.
Opolski, A. Gorski, and C. Radzikowski. 2009. Antitumor effect of
combined treatment of mice with cytostatic agents and bacteriophage T4.
Anticancer Res. 29:2361-2370.
28. El-Shibiny, A., A. Scott, A. Timms, Y. Metawea, P. Connerton, and I.
Connerton. 2009. Application of a group II Campylobacter bacteriophage
to reduce strains of Campylobacter jejuni and Campylobacter coli
colonizing broiler chickens. J. Food Prot. 72:733-740.
3
29. Lin, J. 2009. Novel approaches for Campylobacter control in poultry.
Foodborne. Pathog. Dis. 6:755-765.
30. Synnott, A. J., Y. Kuang, M. Kurimoto, K. Yamamichi, H. Iwano, and Y.
Tanji. 2009. Isolation from sewage influent and characterization of novel
Staphylococcus aureus bacteriophages with wide host ranges and potent
lytic capabilities. Appl. Environ. Microbiol. 75:4483-4490.
31. Rozema, E. A., T. P. Stephens, S. J. Bach, E. K. Okine, R. P. Johnson,
K. Stanford, and T. A. McAllister. 2009. Oral and rectal administration of
bacteriophages for control of Escherichia coli O157:H7 in feedlot cattle. J.
Food Prot. 72:241-250.
32. Kurzepa, A., K. Dabrowska, K. Switala-Jelen, and A. Gorski. 2009.
Molecular modification of T4 bacteriophage proteins and its potential
application - review. Folia Microbiol. (Praha) 54:5-15.
33. Deresinski, S. 2009. Bacteriophage therapy: exploiting smaller fleas. Clin.
Infect. Dis. 48:1096-1101.
34. Seed, K. D. and J. J. Dennis. 2009. Experimental bacteriophage therapy
increases survival of Galleria mellonella larvae infected with clinically
relevant strains of the Burkholderia cepacia complex. Antimicrob. Agents
Chemother. 53:2205-2208.
35. Hurley, A., J. J. Maurer, and M. D. Lee. 2008. Using bacteriophages to
modulate Salmonella colonization of the chicken's gastrointestinal tract:
lessons learned from in silico and in vivo modeling. Avian Dis. 52:599-607.
36. Mattey, M. and J. Spencer. 2008. Bacteriophage therapy--cooked goose
or phoenix rising? Curr. Opin. Biotechnol. 19:608-612.
37. Cairns, B. J. and R. J. Payne. 2008. Bacteriophage therapy and the
mutant selection window. Antimicrob. Agents Chemother. 52:4344-4350.
38. Golshahi, L., K. D. Seed, J. J. Dennis, and W. H. Finlay. 2008. Toward
modern inhalational bacteriophage therapy: nebulization of
bacteriophages of Burkholderia cepacia complex. J. Aerosol Med. Pulm.
Drug Deliv. 21:351-360.
39. Fortuna, W., R. Miedzybrodzki, B. Weber-Dabrowska, and A. Gorski.
2008. Bacteriophage therapy in children: facts and prospects. Med. Sci.
Monit. 14:RA126-RA132.
40. Higgins, J. P., R. L. ndreatti Filho, S. E. Higgins, A. D. Wolfenden, G.
Tellez, and B. M. Hargis. 2008. Evaluation of Salmonella-lytic properties
of bacteriophages isolated from commercial broiler houses. Avian Dis.
52:139-142.
4
41. Kim, K. P., J. D. Cha, E. H. Jang, J. Klumpp, S. Hagens, W. D. Hardt, K.
Y. Lee, and M. J. Loessner. 2008. PEGylation of bacteriophages
increases blood circulation time and reduces T-helper type 1 immune
response. Microb. Biotechnol. 1:247-257.
42. Freitag, T., R. A. Squires, and J. Schmid. 2008. Naturally occurring
bacteriophages lyse a large proportion of canine and feline uropathogenic
Escherichia coli isolates in vitro. Res. Vet. Sci. 85:1-7.
43. Hanlon, G. W. 2007. Bacteriophages: an appraisal of their role in the
treatment of bacterial infections. Int. J. Antimicrob. Agents 30:118-128.
44. Atterbury, R. J., M. A. Van Bergen, F. Ortiz, M. A. Lovell, J. A. Harris,
B. A. De, J. A. Wagenaar, V. M. Allen, and P. A. Barrow. 2007.
Bacteriophage therapy to reduce salmonella colonization of broiler
chickens. Appl. Environ. Microbiol. 73:4543-4549.
45. Weber-Dabrowska, B., M. Zimecki, M. Kruzel, I. Kochanowska, and M.
Lusiak-Szelachowska. 2006. Alternative therapies in antibiotic-resistant
infection. Adv. Med. Sci. 51:242-244.
46. Watanabe, R., T. Matsumoto, G. Sano, Y. Ishii, K. Tateda, Y.
Sumiyama, J. Uchiyama, S. Sakurai, S. Matsuzaki, S. Imai, and K.
Yamaguchi. 2007. Efficacy of bacteriophage therapy against gut-derived
sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob. Agents
Chemother. 51:446-452.
47. Wagenaar, J. A., D. J. Mevius, and A. H. Havelaar. 2006.
Campylobacter in primary animal production and control strategies to
reduce the burden of human campylobacteriosis. Rev. Sci. Tech.
25:581-594.
48. Leszczynski, P., B. Weber-Dabrowska, M. Kohutnicka, M. Luczak, A.
Gorecki, and A. Gorski. 2006. Successful eradication of
methicillin-resistant Staphylococcus aureus (MRSA) intestinal carrier
status in a healthcare worker--case report. Folia Microbiol. (Praha)
51:236-238.
49. Gill, J. J., J. C. Pacan, M. E. Carson, K. E. Leslie, M. W. Griffiths, and
P. M. Sabour. 2006. Efficacy and pharmacokinetics of bacteriophage
therapy in treatment of subclinical Staphylococcus aureus mastitis in
lactating dairy cattle. Antimicrob. Agents Chemother. 50:2912-2918.
50. Vinodkumar, C. S., Y. F. Neelagund, and S. Kalsurmath. 2005.
Bacteriophage in the treatment of experimental septicemic mice from a
clinical isolate of multidrug resistant Klebsiella pneumoniae. J. Commun.
Dis. 37:18-29.
5
51. Loc, C. C., R. J. Atterbury, A. el-Shibiny, P. L. Connerton, E. Dillon, A.
Scott, and I. F. Connerton. 2005. Bacteriophage therapy to reduce
Campylobacter jejuni colonization of broiler chickens. Appl. Environ.
Microbiol. 71:6554-6563.
52. Matsuzaki, S., M. Rashel, J. Uchiyama, S. Sakurai, T. Ujihara, M.
Kuroda, M. Ikeuchi, T. Tani, M. Fujieda, H. Wakiguchi, and S. Imai.
2005. Bacteriophage therapy: a revitalized therapy against bacterial
infectious diseases. J. Infect. Chemother. 11:211-219.
53. Cherwonogrodzky, J. W. 2005. Research strategies for the treatment of
biothreats. Curr. Opin. Pharmacol. 5:465-472.
54. Parfitt, T. 2005. Georgia: an unlikely stronghold for bacteriophage therapy.
Lancet 365:2166-2167.
55. Matsuda, T., T. A. Freeman, D. W. Hilbert, M. Duff, M. Fuortes, P. P.
Stapleton, and J. M. Daly. 2005. Lysis-deficient bacteriophage therapy
decreases endotoxin and inflammatory mediator release and improves
survival in a murine peritonitis model. Surgery 137:639-646.
56. Hagens, S., A. Habel, A. U. von, G. A. von, and U. Blasi. 2004. Therapy
of experimental pseudomonas infections with a nonreplicating genetically
modified phage. Antimicrob. Agents Chemother. 48:3817-3822.
57. Koch, S., M. Hufnagel, and J. Huebner. 2004. Treatment and prevention
of enterococcal infections--alternative and experimental approaches.
Expert. Opin. Biol. Ther. 4:1519-1531.
58. Goodridge, L. D. 2004. Bacteriophage biocontrol of plant pathogens: fact
or fiction? Trends Biotechnol. 22:384-385.
59. Mathur, M. D., S. Vidhani, and P. L. Mehndiratta. 2003. Bacteriophage
therapy: an alternative to conventional antibiotics. J. Assoc. Physicians
India 51:593-596.
60. Connerton, P. L., C. M. Loc Carrillo, C. Swift, E. Dillon, A. Scott, C. E.
Rees, C. E. Dodd, J. Frost, and I. F. Connerton. 2004. Longitudinal
study of Campylobacter jejuni bacteriophages and their hosts from broiler
chickens. Appl. Environ. Microbiol. 70:3877-3883.
61. Boratynski, J., D. Syper, B. Weber-Dabrowska, M.
Lusiak-Szelachowska, G. Pozniak, and A. Gorski. 2004. Preparation of
endotoxin-free bacteriophages. Cell Mol. Biol. Lett. 9:253-259.
62. McGrath, S., G. F. Fitzgerald, and S. D. van. 2004. The impact of
bacteriophage genomics. Curr. Opin. Biotechnol. 15:94-99.
6
63. Nevasaari, K. 2003. [Bacteriophage therapy and colleague Martin
Arrowsmith]. Duodecim 119 :1367.
64. Platt, R., D. L. Reynolds, and G. J. Phillips. 2003. Development of a
novel method of lytic phage delivery by use of a bacteriophage P22
site-specific recombination system. FEMS Microbiol. Lett. 223:259-265.
65. Merril, C. R., D. Scholl, and S. L. Adhya. 2003. The prospect for
bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov.
2:489-497.
66. Huovinen, P. 2003. [Bacteriophage therapy]. Duodecim 119:581-583.
67. Payne, R. J. and V. A. Jansen. 2003. Pharmacokinetic principles of
bacteriophage therapy. Clin. Pharmacokinet. 42:315-325.
68. Kaulen, H. 2003. [Bacteriophage therapy: Stalin's forgotten medicine].
Dtsch. Med. Wochenschr. 128:307.
69. Stone, R. 2002. Bacteriophage therapy. Food and agriculture: testing
grounds for phage therapy. Science 298:730.
70. Stone, R. 2002. Bacteriophage therapy. Stalin's forgotten cure. Science
298:728-731.
71. Wegrzyn, G. and M. S. Thomas. 2002. Modulation of the susceptibility of
intestinal bacteria to bacteriophages in response to Ag43 phase variation
-- a hypothesis. Med. Sci. Monit. 8:HY15-HY18.
72. Nakai, T. and S. C. Park. 2002. Bacteriophage therapy of infectious
diseases in aquaculture. Res. Microbiol. 153:13-18.
73. Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R.
Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice
bacteremic from a clinical isolate of vancomycin-resistant Enterococcus
faecium. Infect. Immun. 70:204-210.
74. Sulakvelidze, A. and J. G. Morris, Jr. 2001. Bacteriophages as
therapeutic agents. Ann. Med. 33:507-509.
75. Summers, W. C. 2001. Bacteriophage therapy. Annu. Rev. Microbiol.
55:437-451.
76. Lakhno, V. M. and V. N. Bordunovskii. 2001. [Use of bacteriophage
therapy in surgical practice]. Vestn. Khir. Im I. I. Grek. 160:122-125.
77. Ho, K. 2001. Bacteriophage therapy for bacterial infections. Rekindling a
memory from the pre-antibiotics era. Perspect. Biol. Med. 44:1-16.
7
78. Weber-Dabrowska, B., M. Mulczyk, and A. Gorski. 2000. Bacteriophage
therapy of bacterial infections: an update of our institute's experience.
Arch. Immunol. Ther. Exp. (Warsz. ) 48:547-551.
79. Sulakvelidze, A., Z. Alavidze, and J. G. Morris, Jr. 2001. Bacteriophage
therapy. Antimicrob. Agents Chemother. 45:649-659.
80. Payne, R. J. and V. A. Jansen. 2001. Understanding bacteriophage
therapy as a density-dependent kinetic process. J. Theor. Biol. 208:37-48.
81. Barrow, P. A. and J. S. Soothill. 1997. Bacteriophage therapy and
prophylaxis: rediscovery and renewed assessment of potential. Trends
Microbiol. 5:268-271.
82. Kwarcinski, W., B. Lazarkiewicz, B. Weber-Dabrowska, J. Rudnicki, K.
Kaminski, and M. Sciebura. 1994. [Bacteriophage therapy in the
treatment of recurrent subphrenic and subhepatic abscess with jejunal
fistula after stomach resection]. Pol. Tyg. Lek. 49:535.
83. Dixon, B. 1987. Bacteriophage therapy. Br. Med. J. (Clin. Res. Ed)
294:1168.
84. Slopek, S., B. Weber-Dabrowska, M. Dabrowski, and A.
Kucharewicz-Krukowska. 1987. Results of bacteriophage treatment of
suppurative bacterial infections in the years 1981-1986. Arch. Immunol.
Ther. Exp. (Warsz. ) 35:569-583.
85. Timoshchuk, I. I., E. I. Natsiashvili, T. G. Chanishvili, and G. D.
Meladze. 1985. [Experience with bacteriophage therapy in nonspecific
suppurative lung diseases]. Grudn. Khir.11-13.
86. Slopek, S., I. Durlakowa, B. Weber-Dabrowska, A.
Kucharewicz-Krukowska, M. Dabrowski, and R. Bisikiewicz. 1983.
Results of bacteriophage treatment of suppurative bacterial infections. I.
General evaluation of the results. Arch. Immunol. Ther. Exp. (Warsz. )
31:267-291.
87. Lang, G., P. Kehr, H. Mathevon, J. M. Clavert, P. Sejourne, and J.
Pointu. 1979. [Bacteriophage therapy of septic complications of
orthopaedic surgery (author's transl]. Rev. Chir Orthop. Reparatrice Appar.
Mot. 65:33-37.
88. Lang, G., P. Kehr, H. Mathevon, J. M. Clavert, P. Sejourne, and J.
Pointu. 1979. [Bacteriophage therapy of septic complications of
orthopaedic surgery (author's transl)]. Rev. Chir Orthop. Reparatrice
Appar. Mot. 65:33-37.
8
89. Vartapetov, A. I. 1974. [Materials on the study of bacteriophage therapy
of deep forms of staphyloderma]. Vestn. Dermatol. Venerol.8-11.
90. Peitzman, S. J. 1969. Felix d'Herelle and bacteriophage therapy. Trans.
Stud. Coll. Physicians Phila 37:115-123.
91. Wittig, H. J., J. F. Raffetto, and R. Bason. 1966. Bacteriophage therapy
in infective childhood asthma. JAMA 196:435.
92. WITOSZKA, M. and B. STRUMILLO. 1963. [BACTERIOPHAGE
THERAPY OF INFECTED SURGICAL WOUNDS]. Pol. Tyg. Lek.
18:430-432.
93. CLAEYS, R. 1962. [Study on a product with antibiotic action:
antibiophagin]. Acta Otorhinolaryngol. Belg. 16:32-38.
94. RAIGA, A. 1948. [Not Available]. Gaz. Med. Fr. 55:693-695.
95. DESRANLEAU, J. M. 1948. The treatment of typhoid fever by the use of
Vi antityphoid bacteriophages; a preliminary report. Can. J. Public Health
39:317-319.
96. BERTARELLI, E. 1948. [Not Available]. Minerva Med. 39:362.
97. DESAULLES, P. and R. LAMY. 1947. [Not Available]. Ann. Inst. Pasteur
(Paris) 73:1145-1150.
98. ZABEZHINSKY, L. M. and L. A. GORSTKINA-SHEVANDRONOVA.
1946. [Phage therapy of typhoid]. Zh. Mikrobiol. Epidemiol.
Immunobiol.25-27.
99. GORDYSHEVSKY, T. I. 1945. [Use of bacteriophage in treatment of
wounds in oto-rhino-laryngology]. Vestn. Otorinolaringol. 7:27-31.
100. Manwaring, W. H. 1935. Deleterious Effects of "Bacteriophage" Therapy.
Cal. West Med. 43 :182.
9